Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis.
Christopher S StrouseMelissa C LarsonShawna L EhlersKathleen J YostMatthew John MaurerStephen M AnsellDavid J InwardsPatrick B JohnstonIvana N MicallefBrian L LinkUmar FarooqJames R CerhanCarrie A ThompsonPublished in: JCO oncology practice (2022)
Patients remaining in remission at 3 and 6 years after diagnosis had a high level of QOL with no significant differences associated with history of treatment with autoHCT.